Former UK IPO star Nanopore admits it is a takeover target
The boss of the UK biotech seen as a beacon of hope for the London IPO market only four years ago has admitted the business has become a takeover target. Oxford Nanopore’s chief executive and co-founder Gordon Sanghera told the Financial Times that the gene sequencing company, whose shares have fallen 85 per cent from … Read more